Logo image of EPAY

BOTTOMLINE TECHNOLOGIES (DE) (EPAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPAY - US1013881065 - Common Stock

56.99
+0.49 (+0.87%)
Last: 5/12/2022, 8:00:02 PM
56.98
-0.01 (-0.02%)
After Hours: 5/12/2022, 8:00:02 PM
Fundamental Rating

2

Overall EPAY gets a fundamental rating of 2 out of 10. We evaluated EPAY against 276 industry peers in the Software industry. EPAY has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EPAY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EPAY was profitable.
EPAY Yearly Net Income VS EBIT VS OCF VS FCFEPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA -4.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPAY Yearly ROA, ROE, ROICEPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -5 -10

1.3 Margins

Industry RankSector Rank
OM -6.37%
PM (TTM) -7.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPAY Yearly Profit, Operating, Gross MarginsEPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EPAY has more shares outstanding
EPAY has a better debt/assets ratio than last year.
EPAY Yearly Shares OutstandingEPAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
EPAY Yearly Total Debt VS Total AssetsEPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 4.32 indicates that EPAY is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.31 indicates that EPAY is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 4.32
ROIC/WACCN/A
WACCN/A
EPAY Yearly LT Debt VS Equity VS FCFEPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.3 Liquidity

EPAY has a Current Ratio of 1.35. This is a normal value and indicates that EPAY is financially healthy and should not expect problems in meeting its short term obligations.
EPAY has a Quick Ratio of 1.35. This is a normal value and indicates that EPAY is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
EPAY Yearly Current Assets VS Current LiabilitesEPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for EPAY have decreased by -0.86% in the last year.
The Earnings Per Share has been decreasing by -5.43% on average over the past years.
Looking at the last year, EPAY shows a quite strong growth in Revenue. The Revenue has grown by 10.10% in the last year.
Measured over the past years, EPAY shows a small growth in Revenue. The Revenue has been growing by 6.55% on average per year.
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y-5.43%
EPS Q2Q%-56.74%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y6.55%
Sales Q2Q%9.05%

3.2 Future

Based on estimates for the next years, EPAY will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.45% on average per year.
Based on estimates for the next years, EPAY will show a quite strong growth in Revenue. The Revenue will grow by 10.84% on average per year.
EPS Next Y-0.66%
EPS Next 2Y10.03%
EPS Next 3Y11.31%
EPS Next 5Y13.45%
Revenue Next Year10.2%
Revenue Next 2Y11.31%
Revenue Next 3Y11.1%
Revenue Next 5Y10.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EPAY Yearly Revenue VS EstimatesEPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
EPAY Yearly EPS VS EstimatesEPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.56 indicates a quite expensive valuation of EPAY.
When comparing the Price/Earnings ratio of EPAY to the average of the S&P500 Index (26.60), we can say EPAY is valued expensively.
A Price/Forward Earnings ratio of 40.93 indicates a quite expensive valuation of EPAY.
The average S&P500 Price/Forward Earnings ratio is at 23.23. EPAY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 49.56
Fwd PE 40.93
EPAY Price Earnings VS Forward Price EarningsEPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 97.24
EPAY Per share dataEPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.03%
EPS Next 3Y11.31%

More info and screens

0

5. Dividend

5.1 Amount

EPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOTTOMLINE TECHNOLOGIES (DE)

NASDAQ:EPAY (5/12/2022, 8:00:02 PM)

After market: 56.98 -0.01 (-0.02%)

56.99

+0.49 (+0.87%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-11 2022-03-11/amc
Earnings (Next)05-24 2022-05-24/amc
Inst Owners3.07%
Inst Owner Change0%
Ins Owners2.01%
Ins Owner Change0%
Market Cap2.59B
Revenue(TTM)506.37M
Net Income(TTM)-36.35M
Analysts49.23
Price Target56.87 (-0.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.56
Fwd PE 40.93
P/S 5.11
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB N/A
EV/EBITDA 97.24
EPS(TTM)1.15
EY2.02%
EPS(NY)1.39
Fwd EY2.44%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.16
BVpS9.18
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -6.37%
PM (TTM) -7.18%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 4.32
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y-5.43%
EPS Q2Q%-56.74%
EPS Next Y-0.66%
EPS Next 2Y10.03%
EPS Next 3Y11.31%
EPS Next 5Y13.45%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y6.55%
Sales Q2Q%9.05%
Revenue Next Year10.2%
Revenue Next 2Y11.31%
Revenue Next 3Y11.1%
Revenue Next 5Y10.84%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BOTTOMLINE TECHNOLOGIES (DE) / EPAY FAQ

Can you provide the ChartMill fundamental rating for BOTTOMLINE TECHNOLOGIES (DE)?

ChartMill assigns a fundamental rating of 3 / 10 to EPAY.


What is the valuation status of BOTTOMLINE TECHNOLOGIES (DE) (EPAY) stock?

ChartMill assigns a valuation rating of 0 / 10 to BOTTOMLINE TECHNOLOGIES (DE) (EPAY). This can be considered as Overvalued.


Can you provide the profitability details for BOTTOMLINE TECHNOLOGIES (DE)?

BOTTOMLINE TECHNOLOGIES (DE) (EPAY) has a profitability rating of 3 / 10.


Can you provide the financial health for EPAY stock?

The financial health rating of BOTTOMLINE TECHNOLOGIES (DE) (EPAY) is 4 / 10.